The Macerich Company (NYSE:MAC – Get Free Report) announced a quarterly dividend on Thursday, October 31st, Zacks reports. Investors of record on Tuesday, November 12th will be paid a dividend of 0.17 per share by the real estate investment trust on Monday, December 2nd. This represents a $0.68 dividend on an annualized basis and a yield of 3.71%. The ex-dividend date is Tuesday, November 12th.
Macerich has increased its dividend payment by an average of 139.8% per year over the last three years. Macerich has a payout ratio of -377.8% indicating that the company cannot currently cover its dividend with earnings alone and is relying on its balance sheet to cover its dividend payments. Equities analysts expect Macerich to earn $1.63 per share next year, which means the company should continue to be able to cover its $0.68 annual dividend with an expected future payout ratio of 41.7%.
Macerich Stock Performance
Shares of NYSE MAC opened at $18.32 on Friday. The stock’s fifty day simple moving average is $17.24 and its 200 day simple moving average is $15.91. The stock has a market capitalization of $3.96 billion, a price-to-earnings ratio of -55.51, a PEG ratio of 0.63 and a beta of 2.50. The company has a quick ratio of 0.86, a current ratio of 0.86 and a debt-to-equity ratio of 1.76. Macerich has a 52-week low of $9.90 and a 52-week high of $19.09.
Analysts Set New Price Targets
About Macerich
Macerich is a fully integrated, self-managed and self-administered real estate investment trust (REIT). As a leading owner, operator and developer of high-quality retail real estate in densely populated and attractive U.S. markets, Macerich’s portfolio is concentrated in California, the Pacific Northwest, Phoenix/Scottsdale, and the Metro New York to Washington, DC corridor.
Featured Stories
- Five stocks we like better than Macerich
- The 3 Best Fintech Stocks to Buy Now
- Battle of the Retailers: Who Comes Out on Top?
- How to Use High Beta Stocks to Maximize Your Investing Profits
- HCA Healthcare: Temporary Setbacks, Long-Term Strength
- Quiet Period Expirations Explained
- MarketBeat Week in Review – 10/28 – 11/1
Receive News & Ratings for Macerich Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Macerich and related companies with MarketBeat.com's FREE daily email newsletter.